Entacapone reduces cortical activation in Parkinson's disease with wearing-off: a f-MRI study.
<h4>Background and purpose</h4>Wearing-off is one of the most frequent problems encountered by levodopa-treated patients. Entacapone, a peripheral inhibitor of catechol-O-methyltransferase (COMT), reduces this motor complication by prolonging the effect of levodopa. We sought to understa...
Guardado en:
Autores principales: | Nicola Tambasco, Marco Muti, Pietro Chiarini, Roberto Tarducci, Stefano Caproni, Anna Castrioto, Pasquale Nigro, Lucilla Parnetti, Pietro Floridi, Aroldo Rossi, Paolo Calabresi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/af39b1d1cef64071ab39c349b1eb0fb5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DETERMINATION OF ANTIPARKINSONISM DRUG ENTACAPONE
por: GADALLAH MOHAMED,NASHWAH, et al.
Publicado: (2010) -
Wearing-off in Parkinson’s disease: neuropsychological differences between on and off periods
por: Caillava-Santos F, et al.
Publicado: (2015) -
Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo&reg;)
por: Paolo Solla, et al.
Publicado: (2010) -
Optimizing levodopa therapy for Parkinson&rsquo;s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective
por: David J Brooks
Publicado: (2008) -
Visualization of cortical projection neurons with retrograde TET-off lentiviral vector.
por: Akiya Watakabe, et al.
Publicado: (2012)